Related Experiment Video

Updated: Sep 2, 2026

Localization, Identification, and Excision of Murine Adipose Depots
08:53

Localization, Identification, and Excision of Murine Adipose Depots

Published on: December 4, 2014

[Primary exogenous obesity]

R Piñeiro Lamas, L Peña Alonso, J González Hernández

    Boletin Medico Del Hospital Infantil De Mexico
    |July 1, 1980
    PubMed

    Insights

    Early-onset childhood obesity, often starting within the first year of life, is strongly linked to parental obesity and family history. This highlights the critical role of early detection and intervention for pediatric obesity.

    Area of Science:

    • Pediatric Endocrinology
    • Public Health

    Context:

    • Childhood obesity is a growing global health concern.
    • Understanding the early developmental factors of pediatric obesity is crucial for effective management.

    Purpose:

    • To investigate the onset and familial factors associated with obesity in a cohort of children aged 5-14 years.
    • To analyze the relationship between the age of obesity onset, birth weight, parental obesity, and family history of diseases.

    Summary:

    • A study of 214 obese children (ages 5-14) found that 51.87% experienced obesity onset within their first year of life.
    • A strong correlation exists between the severity of obesity and its early onset. Parental obesity was present in 88.3% of cases.
    • While birth weight did not correlate with obesity intensity, early onset significantly predicted severity. Familial history of diabetes mellitus and obesity were also noted.

    Impact:

    • Emphasizes the importance of identifying familial antecedents and the early course of obesity in children.
    • Provides insights for targeted prevention and treatment strategies for pediatric obesity.
    • Highlights the critical window during the first year of life for obesity development and intervention.

    More Related Videos

    Multidisciplinary Approach to Obesity Management: A Case Report05:10

    Multidisciplinary Approach to Obesity Management: A Case Report

    Published on: May 30, 2025

    Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas03:07

    Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas

    Published on: November 11, 2025

    Related Concept Videos

    Obesity01:24

    Obesity

    The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
    Drug Dosing: Obese Patients01:21

    Drug Dosing: Obese Patients

    In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
    Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

    Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

    Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
    Cushing Syndrome I: Introduction01:26

    Cushing Syndrome I: Introduction

    Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
    Cushing Syndrome II: Pathophysiology01:19

    Cushing Syndrome II: Pathophysiology

    Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
    Type II Diabetes I: Introduction01:26

    Type II Diabetes I: Introduction

    Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...